The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Paul A. Meyers

Department of Pediatrics

Memorial Sloan-Kettering Cancer Center

New York

New York 10065

USA

[email]@mskcc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. 1998 - 2011
  • Children's Oncology Group, Arcadia, USA. 2008

References

  1. Addition of pamidronate to chemotherapy for the treatment of osteosarcoma. Meyers, P.A., Healey, J.H., Chou, A.J., Wexler, L.H., Merola, P.R., Morris, C.D., Laquaglia, M.P., Kellick, M.G., Abramson, S.J., Gorlick, R. Cancer (2011) [Pubmed]
  2. Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. Meyers, P.A. Expert. Rev. Anticancer. Ther (2009) [Pubmed]
  3. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. Meyers, P.A., Schwartz, C.L., Krailo, M.D., Healey, J.H., Bernstein, M.L., Betcher, D., Ferguson, W.S., Gebhardt, M.C., Goorin, A.M., Harris, M., Kleinerman, E., Link, M.P., Nadel, H., Nieder, M., Siegal, G.P., Weiner, M.A., Wells, R.J., Womer, R.B., Grier, H.E. J. Clin. Oncol. (2008) [Pubmed]
  4. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Meyers, P.A., Schwartz, C.L., Krailo, M., Kleinerman, E.S., Betcher, D., Bernstein, M.L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A.M., Harris, M.B., Healey, J., Huvos, A., Link, M., Montebello, J., Nadel, H., Nieder, M., Sato, J., Siegal, G., Weiner, M., Wells, R., Wold, L., Womer, R., Grier, H. J. Clin. Oncol. (2005) [Pubmed]
  5. High-dose therapy with autologous stem cell rescue for pediatric sarcomas. Meyers, P.A. Curr. Opin. Oncol (2004) [Pubmed]
  6. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. Kolb, E.A., Kushner, B.H., Gorlick, R., Laverdiere, C., Healey, J.H., LaQuaglia, M.P., Huvos, A.G., Qin, J., Vu, H.T., Wexler, L., Wolden, S., Meyers, P.A. J. Clin. Oncol. (2003) [Pubmed]
  7. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. Meyers, P.A., Krailo, M.D., Ladanyi, M., Chan, K.W., Sailer, S.L., Dickman, P.S., Baker, D.L., Davis, J.H., Gerbing, R.B., Grovas, A., Herzog, C.E., Lindsley, K.L., Liu-Mares, W., Nachman, J.B., Sieger, L., Wadman, J., Gorlick, R.G. J. Clin. Oncol. (2001) [Pubmed]
  8. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. Meyers, P.A., Gorlick, R., Heller, G., Casper, E., Lane, J., Huvos, A.G., Healey, J.H. J. Clin. Oncol. (1998) [Pubmed]
 
WikiGenes - Universities